BVS Valuation
Bioventus Inc
$
6.800
- Overview
- Forecast
- Valuation
BVS Relative Valuation
BVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BVS is overvalued; if below, it's undervalued.
Historical Valuation
Bioventus Inc (BVS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.72 is considered Undervalued compared with the five-year average of 0.91. The fair price of Bioventus Inc (BVS) is between 10.48 to 17.56 according to relative valuation methord. Compared to the current price of 6.80 USD , Bioventus Inc is Undervalued By 35.14%.
Relative Value
Fair Zone
10.48-17.56
Current Price：6.80
35.14%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.95
P/B
Median3y
2.06
Median5y
2.50
5.82
FCF Yield
Median3y
-0.80
Median5y
0.74
Competitors Valuation Multiple
The average P/S ratio for BVS's competitors is 3.26, providing a benchmark for relative valuation. Bioventus Inc Corp (BVS) exhibits a P/S ratio of 0.72, which is -77.96% above the industry average. Given its robust revenue growth of -4.31%, this premium appears unsustainable.
People Also Watch
VACH
Voyager Acquisition Corp
10.290
USD
+0.15%
VMD
Viemed Healthcare Inc
6.420
USD
-11.69%
GOCO
Gohealth Inc
8.370
USD
-1.41%
SPOK
Spok Holdings Inc
16.540
USD
+0.36%
MVIS
MicroVision Inc
1.150
USD
+1.77%
CMRX
Chimerix Inc
8.540
USD
-0.12%
XOMA
XOMA Corp
24.440
USD
-0.16%
PGEN
Precigen Inc
1.350
USD
0.00%
LPA
Logistic Properties of The Americas
6.400
USD
+4.58%
PBPB
Potbelly Corp
10.110
USD
+18.11%
FAQ
Is Bioventus Inc (BVS) currently overvalued or undervalued?
Bioventus Inc (BVS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.68 is considered Undervalued compared with the five-year average of 0.91. The fair price of Bioventus Inc (BVS) is between 10.48 to 17.56 according to relative valuation methord. Compared to the current price of 6.80 USD , Bioventus Inc is Undervalued By 35.14% .
What is Bioventus Inc (BVS) fair value?
How does BVS's valuation metrics compare to the industry average?
What is the current P/B ratio for Bioventus Inc (BVS) as of May 09 2025?
What is the current FCF Yield for Bioventus Inc (BVS) as of May 09 2025?
What is the current Forward P/E ratio for Bioventus Inc (BVS) as of May 09 2025?